Recombinant Stem Cells as Carriers for Cancer Gene Therapy
Recent studies have shown the ability of mesenchymal stem cells (MSCs) to migrate toward and engraft into the tumor sites, which provides a potential for their use as carriers for cancer gene therapy. Here, we describe the strategies of using MSCs as carriers for cancer gene therapy using a nonviral transfection method.
Source: Springer protocols feed by Biotechnology - Category: Biotechnology Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Stem Cell Therapy | Stem Cells | Study